Los Angeles Capital Management LLC Gilead Sciences, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 417,053 shares of GILD stock, worth $38.6 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
417,053
Previous 678,989
38.58%
Holding current value
$38.6 Million
Previous $46.6 Million
24.96%
% of portfolio
0.14%
Previous 0.17%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.7 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.09 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.72 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.57 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $116B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...